The International HPV Laboratory Network (LabNet) was created by WHO in 2005 to support the world-wide development and implementation of HPV vaccines through improved laboratory standardization and quality assurance of HPV testing and typing for research and evaluation of HPV vaccines. As part of this strategy, the International HPV Reference Center has organized and issued global Proficiency Panels (sets of blinded samples containing HPV genotypes at different concentrations) since 2008.
The Proficiency Study takes place every one to two years, and is an indicator of the participating laboratories’ expertise and competence, as well as the proficiency of their chosen HPV testing platform/assay. Since 2010, labs using DiagCor’s GenoFlowTM HPV Array Test Kit have participated in the program, and consistently attained fully proficient (100% Proficient) status. In the most recent 2019 program, now published here, the GenoFlowTM HPV Array Test Kit was again fully proficient, and superior to other commonly used commercial assays.
In addition to the HPV compositions listed in the proficiency panel, GenoFlowTM HPV Array Test Kit can genotype a total of 33 high- and low-risk HPV subtypes. DiagCor Life Science prioritises high product quality and actively supports HPV testing services in laboratories worldwide, thus contributing to the elimination of cervical cancer.
Read more about GenoFlowTM HPV Array Test Kit here, and please get in touch to learn more.
Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.
DiagCor Life Science